ImmunAG: Phyto-therapy and human civilization
On the hunt for non-cannabis CB2 modulators, ImmunAG shares this report regarding producing CBDx and other cannabinoids from a variety of hops.
Yona Levy is the CEO of Alvit Pharma, an Israeli-based company specializing in the development of pharma-grade cannabis products. With over 20 years of experience in business management and investment banking, Levy has brought his skills to the cannabis industry, and with the team at Alvit, they aim to lead the world in the standardization, optimization, and delivery of products alternative to smoking medicinal cannabis.
It's not uncommon these days to see former chemists and molecular biologists move from the pharmaceutical industry into cannabis. It's just a logical next step into a growing sector. But to see a former NASA funded scientist, like for Shellene Suemori, move into cannabis, is an interesting move.
Regardless of the product, when a new industry emerges, opportunities arise for early adopters to jump into highly rewarding positions in an exciting new field. With industries as promising as cannabis and hemp, many people are finding new ways to incorporate skills and expertise, learned from more mainstream industries, to forge a new path during the early days of the Green Rush.
Summertime in Colorado is known for a vast selection of experiences for the everyday tourist, locals, and someone like myself, a weekend warrior. There are so many things happening at any given moment in our state to indulge in. However, for some of us, summertime in Colorado also represents regulation implementation dates. Such as July 1, as it seems almost every summer there is a new packaging or labeling rule to adhere to and the beginning of Colorado’s State licensing authority summer rule-making sessions.
You may have seen Dr. Sanjay Gupta’s series about cannabis on CNN. He was at one time a critic of marijuana, but in a widely publicized article, “Why I Changed My Mind on Weed,” he wrote: “I traveled around the world to interview medical leaders, experts, growers and patients. I spoke candidly to them, asking tough questions. What I found was stunning.”